Page last updated: 2024-11-08

streptothricins

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Streptothricins: A group of antibiotic aminoglycosides differing only in the number of repeating residues in the peptide side chain. They are produced by Streptomyces and Actinomyces and may have broad spectrum antimicrobial and some antiviral properties. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

streptothricin : An N-glycosyl compound consisting of 2-amino-4-O-carbamoyl-2-deoxy-N-[(3aS,7R,7aS)-7-hydroxy-4-oxooctahydro-2H-imidazo[4,5-c]pyridin-2-ylidene]-beta-D-gulopyranosylamine in which the amino group at position 2 of the gulopyranosyl moiety is acylated by a peptide unit made up of between 1 and 7 N(epsilon)-linked units of beta-lysine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID475825
MeSH IDM0020598

Synonyms (7)

Synonym
54003-27-9
streptothricins
[6-[(e)-[(3as,7r,7as)-7-hydroxy-4-oxo-3,3a,5,6,7,7a-hexahydro-1h-imidazo[4,5-c]pyridin-2-ylidene]amino]-5-(3,6-diaminohexanoylamino)-4-hydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl] carbamate
streptothricin
einecs 258-911-6
[6-[[(3as,7r,7as)-7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-2-yl]amino]-5-(3,6-diaminohexanoylamino)-4-hydroxy-2-(hydroxymethyl)oxan-3-yl] carbamate
DTXSID60202321

Research Excerpts

Overview

Streptothricins are a group of the earliest discovered antibiotics with broad antimicrobial spectrum. They have been used for crop protection.

ExcerptReferenceRelevance
"Streptothricins are a group of the earliest discovered antibiotics with broad antimicrobial spectrum, and have been used for crop protection. "( [Progress in streptothricin antibiotics - A review].
Chen, Y; Li, J; Wang, M, 2016
)
1.88
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (255)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990153 (60.00)18.7374
1990's23 (9.02)18.2507
2000's31 (12.16)29.6817
2010's40 (15.69)24.3611
2020's8 (3.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.35 (24.57)
Research Supply Index5.62 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (2.91%)6.00%
Case Studies1 (0.36%)4.05%
Observational1 (0.36%)0.25%
Other265 (96.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]